Contribution of OMICS to prediction and precision medicine of type II diabetes
“Contribution of OMICS to prediction and precision medicine of type II diabetes"
(This webinar is only accessible to industrial actors !)
– Program :
– Dr Amélie Bonnefond, Director of Research – Team Leader – Inserm/CNRS unit #1283/8199 Lille Pasteur Institute, Lille University, Lille University Hospital, EGID.
Scientific director of the next-generation sequencing platform LIGAN. Honorary Senior Scientist – Imperial College London
Expert in human genetics and in next-generation sequencing and OMICS technologies.
– Pr Philippe Froguel, Professor of Endocrinology, Lille University Hospital. Professor of Genomic Medicine, Imperial College London – Faculty of Medicine.
Founding member of the LABEX-EGID (European Genomic Institute for Diabetes) and Director of PreciDIAB-National Center for Precision Diabetic Medicine.
International expert on the genetics of diabetes and obesity.
We invite you to send us any questions you might have for the speakers before the webinar (at least 1 week before) and get the opportunity to have a one-to-one meeting feedback
|SEND YOUR QUESTIONS|